Clearmind Medicine Granted Patent Approval in Hong Kong

Vancouver, Canada, June 28, 2024  — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind”…

Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 — Clearmind Medicine…

Clearmind Medicine Strengthens Scientific Advisory Board with Appointment of Prof. Joseph Tam

Hebrew University of Jerusalem professor is an expert on obesity and metabolic…